Acquiring a Startup? The SEC's New Rule 701 Guidance Creates a Hidden Equity Compliance Trap
You're the CFO of a growth-stage company planning an acquisition. You've done the financial due diligence, the contracts look clean, and the valuation is reasonable. But there's one thing you might not be checking carefully enough: the target company's equity compensation plan compliance.
If the target didn't comply with SEC Rule 701, congratulations — the acquirer just inherited a compliance problem. The target's shareholders could have rescission rights, the employees might have recourse claims, and regulators could be watching. This issue doesn't make headlines, but it destroys deal economics quietly.
Here's what you need to know about Rule 701, the acquisition context, and how to protect your deal.
What Happens to Equity Compensation in an Acquisition
When Company A acquires Company B, the question of what happens to Company B's outstanding stock options and restricted stock is fundamental. There are three basic approaches:
Assumption: The acquirer assumes the target's equity plan and all outstanding awards. Options and RSUs convert into equivalent awards under the acquirer's plan, with the same terms adjusted for the merger. The employees continue to vest on the original schedule, now earning equity in the acquirer.
Substitution: The acquirer issues new awards to the target's employees in place of their old awards. The new awards might be in acquirer stock, cash, or a combination, and they might have different vesting schedules. This is a tactical choice — sometimes substitution is attractive because it lets the acquirer reset incentives and remove dead wood.
Cash-Out: The target's equity is cashed out in the merger. All options and RSUs are settled for cash (either at close or at a later date), and the employees exit the deal with no equity interest in the acquirer. This is common in stock purchases where the acquirer wants a clean start and doesn't want to be burdened with inherited equity plans.
Each approach has tax consequences, retention implications, and deal structure ramifications. But regardless of which approach is used, if the target's equity plan was not compliant with Rule 701, the acquirer has inherited the compliance gap.
The Rule 701 Compliance Problem: What Is Rule 701 and Why Does It Matter?
Rule 701 is an SEC regulation that exempts certain equity compensation arrangements from the registration and disclosure requirements of the securities laws. Essentially, Rule 701 says: if you're a private company issuing equity to employees, directors, consultants, and advisors under a written plan, you don't have to register those securities or comply with most disclosure rules — provided you stay within specific limits and follow specific rules.
Rule 701 limits the aggregate sales price or amount sold in any consecutive 12-month period to the greatest of: (1) $1,000,000, (2) 15% of the issuer's total assets (measured at its most recent balance sheet date), or (3) 15% of the outstanding amount of the class of securities being sold. Separately, Rule 701(e) requires enhanced disclosure when aggregate sales in a 12-month period exceed $10 million—there is no "$25 million" cap in the rule. Sales in excess of the applicable ceiling are not exempt under Rule 701 and may constitute unregistered offers or sales under Section 5 of the Securities Act, exposing the issuer to rescission liability under Section 12(a)(1).
Additionally, Rule 701 restricts who can receive grants (employees, directors, consultants, and advisors — but not all consultants), and it requires that the plan be in writing and contain specific terms. If you grant options to ineligible recipients or don't have a written plan, you've violated Rule 701.
Why does this matter in an acquisition? Because if the target company violated Rule 701 during its lifetime, the acquiring company is now holding the bag. The shareholders (and potentially the employees) of the target have rescission rights — they can demand their purchase price back, or equivalent damages. If the option holders were ineligible, if the plan exceeded the dollar limit, or if key disclosures were missing, these claims could be asserted post-acquisition.
The SEC's Guidance on Post-Acquisition Rule 701 Treatment
The SEC has issued guidance (primarily through the Division of Corporation Finance) addressing Rule 701 in the context of acquisitions. The key points:
First, the SEC has confirmed that Rule 701 compliance is measured at the time of grant — if an option was granted in violation of Rule 701, that violation doesn't cure itself when the company is acquired. The acquiring company cannot retroactively clean up the target's failures.
Second, the SEC has clarified that if the acquirer assumes the target's equity plan, the acquirer should conduct a full Rule 701 audit of the target's prior granting practices. If violations are found, the acquirer may want to either (a) indemnify itself from the target's shareholders, (b) reserve for the cost of rescission claims, or (c) in some cases, negotiate a reduction in purchase price to reflect the contingent liability.
Third, the SEC has indicated that substitution and cash-out transactions don't automatically erase Rule 701 violations of the target. Employees who received ineligible grants under Rule 701 might still have rescission claims against the target company (and thus against the acquiring company if it assumed those liabilities).
In other words: Rule 701 compliance is the target's problem, but it quickly becomes the acquirer's problem.
Common Compliance Gaps Acquirers Discover in Due Diligence
In my experience, these are the Rule 701 problems that show up in equity plan audits:
Dollar Limit Exceeded: The target's aggregate sales price or amount sold in a 12-month period exceeded the Rule 701 ceiling (the greatest of $1,000,000, 15% of total assets, or 15% of the outstanding class), and no enhanced disclosure was made when the $10 million threshold under Rule 701(e) was crossed. This is surprisingly common because early-stage companies sometimes grow faster than expected and grant tracking isn't updated. The compliance failure can affect dozens or hundreds of grants spanning years.
Grants to Ineligible Recipients: The target granted options or RSUs to consultants who weren't eligible under Rule 701, or to board members who weren't directors. Rule 701 is strict about who can receive awards. If the target didn't have a written plan clearly defining eligible recipients, or if the board approved awards to ineligible people anyway, those grants are outside Rule 701's exemption.
Missing or Inadequate Plan Documents: Rule 701 requires a written plan. Surprisingly, some private companies never documented their equity plan properly. They granted options under an informal understanding or a board resolution, but no formal plan document was ever signed and approved. Or the plan document existed but didn't contain the specific terms required by Rule 701 (like the settlement method, the exercise price methodology, or the conditions for termination of vesting).
Failure to Disclose Plan Terms: Rule 701 requires that companies disclose the plan terms to option holders within a reasonable time after grant. Many early-stage companies skip this step or do it haphazardly. Employees might not have received copies of the plan, or received them so long after the grant that the disclosure was arguably untimely.
Grants Outside the Written Plan: The target had a Rule 701-compliant plan for most employees, but then granted options to key advisors or board observers outside the plan. Even a single grant outside the written plan can be a violation.
The Due Diligence Checklist: What Acquirers Should Review
If you're acquiring a company with an equity plan, this is what your legal team should audit:
The Equity Plan Document: Does the target have a written plan? Does it comply with Rule 701 in terms of eligible participants, share limits, vesting schedules, and settlement mechanics? Is it signed and dated? Has it been amended?
Board Approvals: Did the board approve the original plan and each material amendment? Are the approvals documented?
Equity Grant Records: Pull a complete list of every equity grant made — options, RSUs, restricted stock, phantom stock, anything. For each grant, verify: Was the recipient eligible under Rule 701? Was the grant made pursuant to the written plan? Was the grant approved by the board or a committee? Was the grant properly disclosed to the grantee?
Compliance with Dollar Limits: Calculate the aggregate sales price or amount sold in each consecutive 12-month period against the Rule 701 ceiling: the greatest of $1,000,000, 15% of total assets, or 15% of the outstanding class. Also check whether any 12-month period crossed the $10 million threshold triggering enhanced disclosure obligations under Rule 701(e). (Note: the calculation is complex and should be done by counsel, but it's critical.)
Recipient Eligibility: Rule 701 allows grants to employees, directors, consultants, and advisors — but with constraints. Verify that every grant was made to an eligible person. Pay special attention to advisors, board observers, and other non-employee recipients.
Disclosure to Grantees: Did the company provide the plan document and material terms to each grantee in writing? When? Is there evidence of timely disclosure?
Securities Law Analysis: Did the company register the equity plan and grants under state securities laws? (Not required under federal Rule 701 if the exemption is available, but state laws can differ.)
Consequences of Discovering Rule 701 Violations
If the due diligence unearths violations, what are the consequences?
Rescission Rights: Option holders and RSU recipients who received ineligible grants may have the right to demand rescission — essentially, unwinding the grant and returning it to the company in exchange for their consideration back. If an employee paid $X for an option grant that was issued in violation of Rule 701, they might demand their $X back. If it was a grant of RSUs with no monetary payment, the company might owe the fair value of the grant.
Indemnification Claims: If the target's shareholders knew about Rule 701 violations and didn't disclose them, the acquirer might have indemnification rights. Conversely, if the target's shareholders honestly didn't know, indemnification may be unavailable — but the acquirer can still be exposed to rescission claims from employees.
Purchase Price Adjustment: Savvy acquirers will negotiate a purchase price reduction or a holdback in escrow to cover the cost of likely rescission claims or the cost of curing the violations (e.g., by issuing new compliant grants in substitution).
Litigation Risk: If rescission claims are asserted and disputed, the acquirer could face litigation from the target's shareholders. This is costly and disruptive.
Regulatory Scrutiny: In some cases, if the violations are egregious or if rescission claims are asserted, the SEC itself might become interested. This is rare, but it has happened in cases where there's evidence of fraud or willful non-compliance.
How to Fix Problems Found in Diligence
If violations are discovered before closing, there are several remediation options:
Retroactive Plan Amendment: Amend the equity plan retroactively to comply with Rule 701 (e.g., adjust share limits, add missing provisions, clarify eligible recipients). This doesn't erase prior violations, but it can prevent future violations and demonstrates good faith.
Substitution or Repricing: In some cases, the target can reissue compliant grants in substitution for non-compliant ones. For example, if options were granted outside the written plan, the company can retroactively bring them into a compliant plan and have employees acknowledge the revised terms. This doesn't eliminate rescission risk entirely, but it can reduce it.
Indemnity and Holdback: The purchase agreement can include a specific indemnity for Rule 701 violations, with a corresponding holdback of purchase price in escrow. This reserves funds to pay rescission claims or settlements without derailing the acquisition.
Disclosure to Shareholders: The target can disclose the violations to its shareholders and option holders and attempt to resolve claims pre-closing. This is sometimes effective and sometimes not, depending on the magnitude of the violation and the goodwill between the company and the shareholders.
Practical Tips for Target Companies: Clean Up Before Going to Market
If you're a startup founder or CFO thinking about a future acquisition, here's what to do today:
First, make sure you have a written equity plan that complies with Rule 701. This should be done by a lawyer who knows the securities laws, not cobbled together from a template.
Second, document every equity grant. For each option or RSU, keep a board resolution or committee approval, a grant notice, and evidence that you provided the plan terms to the grantee.
Third, track your Rule 701 compliance. Specifically, keep a running calculation of the aggregate sales price or amount sold in each consecutive 12-month period against the applicable ceiling (greatest of $1,000,000, 15% of total assets, or 15% of the outstanding class). Also monitor whether aggregate sales are approaching the $10 million threshold that triggers enhanced disclosure under Rule 701(e). If you're approaching a ceiling, plan accordingly — you might need to obtain shareholder approval or establish a new plan.
Fourth, don't grant equity outside the written plan. If you want to award equity to someone, either put them under the plan or document a separate, carefully crafted securities issuance. Don't assume the exceptions in Rule 701 are narrow enough to protect you if you deviate from the plan.
Clean compliance is an asset when you go to market. It reduces the acquirer's concerns, it simplifies due diligence, and it lets you negotiate from a position of strength.
The Bigger Lesson: Equity Administration Matters
Rule 701 violations aren't about fraud or wrongdoing — they're usually about sloppiness. Early-stage companies are so focused on product and fundraising that equity administration falls into a black hole. Plans aren't documented, grants are approved informally, and compliance is an afterthought.
But when acquisition time comes around, equity administration becomes critical. A target company with sloppy equity practices can face surprise liabilities, purchase price reductions, and post-closing disputes. An acquirer that doesn't audit the target's equity plan can inherit a compliance nightmare.
The lesson: treat equity administration with the seriousness of finance or legal compliance. Document the plan, track the limits, approve grants properly, and disclose to recipients. It takes a few hours upfront and saves thousands or millions in due diligence and litigation downstream.
Related Reading
For more on startup fundraising and securities law, see our Complete Guide to Regulation D, Rule 506(b) vs. 506(c) Comparison, and Accredited Investor Rules.
